Publication Name	World Journal of Stem Cells
Manuscript ID	15519
Country	India

Received	2014-11-28 08:41
Peer-Review Started	2014-12-02 16:40
To Make the First Decision	2015-01-20 13:36
Return for Revision	2015-01-22 14:42
Revised	2015-02-14 17:17
Second Decision	2015-04-03 17:31
Accepted by Journal Editor-in-Chief	2015-04-04 02:27
Accepted by Executive Editor-in-Chief	2015-04-20 14:14
Articles in Press	2015-04-20 14:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-06-12 11:46
Publish the Manuscript Online	2015-06-30 08:56

ISSN	1948-0210 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Hepatic stem cells: A viable approach for the treatment of liver cirrhosis
Manuscript Source	Invited Manuscript
All Author List	Md Aejaz Habeeb, Sandeep Kumar Vishwakarma, Avinash Bardia and Aleem Ahmed Khan
Funding Agency and Grant Number
Corresponding Author	Dr. Aleem Ahmed Khan, Scientist, Center for Liver Research and Diagnostics, Deccan College of Medical Sciences, Hyderabad 500058, Andhra Pradesh, India. aleem_a_khan@rediffmail.com
Key Words	Hepatic stem cells; Bioengineering; Liver cirrhosis; Labeling and tracking
Core Tip	Liver cirrhosis is characterized by distortion of liver architecture, necrosis of hepatocytes and regenerative nodules formation leading to cirrhosis. The available treatment modalities are not very effective against liver cirrhosis. Stem cells are considered one of the potential adjuvant treatment modality in liver cirrhosis patients. Fetal hepatic stem cells transplantation in liver cirrhosis has emerged as an alternative to organ transplantation. However long-term stem cells labeling and tracking is needed for cell fate determination after transplantation. Decellularization technology provides a novel tool to develop bioengineered personalized livers to accomplish the shortage of donor livers.
Publish Date	2015-06-30 08:56
Citation	Habeeb MA, Vishwakarma SK, Bardia A, Khan AA. Hepatic stem cells: A viable approach for the treatment of liver cirrhosis. World J Stem Cells 2015; 7(5): 859-865
URL	http://www.wjgnet.com/1948-0210/full/v7/i5/859.htm
DOI	http://dx.doi.org/10.4252/wjsc.v7.i5.859

Full Article (PDF)	WJSC-7-859.pdf
Full Article (Word)	WJSC-7-859.doc
Manuscript File	15519-Review.docx
Answering Reviewers	15519-Answering reviewers.pdf
Audio Core Tip	15519-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	15519-Conflict-of-interest statement.pdf
Copyright License Agreement	15519-Copyright assignment.pdf
Peer-review Report	15519-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	15519-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	15519-Scientific misconduct check.pdf
Scientific Editor Work List	15519-Scientific editor work list.pdf